YOLFTbeta
Farmacias Benavides S.A.B. de C.V.

Farmacias Benavides S.A.B. de C.V.

BEVIDESB · MX · Healthcare / Pharmaceutical Retailers

25.00MXN+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close25.00
Open25.00
Day Range25.00 – 25.00
52-Week Range25.00 – 26.00
Volume0
Market Cap10.22B
P/E (TTM)37.88
Forward P/E0.00
EPS0.66
Dividend Yield0.00%
Beta0.13
50-Day Avg25.00
200-Day Avg25.63

About

Farmacias Benavides, S.A.B. de C.V. engages in the sale of pharmaceuticals, personal care and beauty products. The company operates through four segments: Health and Wellness, Consumer, Hygiene and Beauty, and Photography. It provides medicinal, nonperishable food, and personal hygiene products, as well as photo development. Farmacias Benavides, S.A.B. de C.V. was founded in 1917 and is based in Monterrey, Mexico. Farmacias Benavides, S.A.B. de C.V. operates as a subsidiary of Walgreens Boots Alliance, Inc.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Mauricio Gonzalez-Luna Gutiérrez-Lascuráin
  • Employees7.75K
  • HeadquartersAvenida Fundadores No. 935 interior 301, Monterrey, NL, Mexico, 64750, Mexico
  • Websitehttps://www.benavides.com.mx

Leadership

  • Mr. Mauricio Gonzalez-Luna Gutiérrez-LascuráinCEO & MD
  • Jose Alfonso Salazar MontalvoFinance Director
  • Mr. Enrique Hinojosa-GallagaSecretary & Legal Director

Financials

Income Statement

Currency: MXN2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Revenue5.53B5.08B4.54B4.88B5.40B6.22B7.40B9.16B9.95B10.05B9.64B10.13B10.62B11.08B11.47B12.75B13.40B13.50B13.81B13.91B13.87B14.74B16.22B17.23B
Growth (%)--8.25%-10.61%+7.59%+10.54%+15.34%+18.86%+23.82%+8.58%+1.03%-4.06%+5.12%+4.83%+4.34%+3.51%+11.14%+5.11%+0.71%+2.34%+0.70%-0.30%+6.30%+10.00%+6.22%
Cost of Revenue-3.85B3.40B3.55B3.89B4.56B5.49B6.85B7.50B7.51B7.40B7.75B8.05B8.31B8.70B9.73B10.02B9.92B9.80B9.73B9.80B10.20B11.29B11.93B
Gross Profit-------------2.62B2.77B3.02B3.39B3.58B4.01B4.18B4.07B4.55B4.92B5.30B
Gross Margin-------------23.62%24.15%23.72%25.28%26.50%29.05%30.04%29.36%30.85%30.37%30.74%
Operating Expense-------------2.21B2.55B2.97B3.41B4.10B4.20B4.00B3.96B4.03B4.22B4.44B
Operating Income68.60M14.09M-32.33M54.82M102.47M195.73M307.32M178.90M193.11M104.70M302.75M372.88M410.88M219.21M55.43M-22.49M-520.16M-183.68M175.08M112.05M516.49M704.30M856.44M
Operating Margin1.24%0.28%-0.66%1.02%1.65%2.65%3.36%1.80%1.92%1.09%2.99%3.51%3.71%1.91%0.43%-0.17%-3.85%-1.33%1.26%0.81%3.50%4.34%4.97%
EBITDA------------------342.08M66.00M705.30M1.10B1.43B1.73B1.84B
EBITDA Margin------------------2.53%0.48%5.07%7.96%9.67%10.68%10.66%
Net Income132.85M----142.18M248.70M246.77M82.33M109.19M86.98M207.60M258.18M298.72M101.20M4.82M-104.68M-683.61M-305.23M-136.70M-278.18M9.71M127.30M282.33M
Net Income Margin2.40%----2.28%3.36%2.69%0.83%1.09%0.90%2.05%2.43%2.70%0.88%0.04%-0.78%-5.06%-2.21%-0.98%-2.01%0.07%0.78%1.64%
R&D---------------42.80M48.10M54.90M------
R&D as % of Total Revenue---------------0.34%0.36%0.41%------
Interest Expense000000000000000000169.59M311.59M403.66M296.00M361.62M413.61M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.23%2.24%2.91%2.01%2.23%2.40%

Balance Sheet

Currency: MXN2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Assets2.66B2.44B2.20B2.33B2.52B2.74B3.22B3.92B4.32B3.95B3.95B4.16B4.41B5.06B5.57B5.30B5.70B5.75B6.40B8.67B7.84B6.88B7.73B8.98B
Total Liabilities1.70B1.68B1.28B1.32B1.38B1.59B1.93B2.50B2.95B2.54B2.62B2.65B2.86B3.51B4.07B3.79B4.29B5.03B5.96B8.39B7.88B6.92B7.54B8.56B
Total Equity921.45M710.81M922.70M1.01B1.14B1.15B1.29B1.42B1.37B1.41B1.33B1.51B1.55B1.55B1.49B1.52B1.41B725.59M441.17M279.65M-39.43M-40.84M181.76M418.05M
Cash61.32M92.07M280.74M186.18M287.13M398.01M337.57M500.82M391.00M147.54M217.17M303.42M314.89M484.74M773.46M394.31M388.37M359.54M393.64M489.14M405.48M495.25M635.54M677.39M
Net Debt-----------------1.10B1.97B1.75B1.57B776.63M359.13M289.15M

Cash Flow

Currency: MXN2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Cash Flow167.21M105.85M176.88M-204.87M379.95M319.99M766.06M255.26M399.75M375.21M240.07M286.14M678.14M472.90M-208.59M-62.40M-1.08B-570.90M627.30M1.05B1.20B1.42B902.53M
Investing Cash Flow---------4.82M----220.16M-53.19M-170.56M-144.85M-202.16M-299.41M-137.73M-111.68M-92.44M-329.88M-
Financing Cash Flow--29.94M-----------288.14M-130.99M201.30M201.30M1.25B904.41M-394.08M-1.02B-1.02B-837.18M-
Capital Expenditure148.24M45.31M15.09M84.28M78.01M146.03M285.92M363.86M340.62M50.67M0121.62M94.66M194.28M171.09M171.09M144.85M346.20M445.91M252.33M222.44M191.78M348.09M242.44M
Free Cash Flow------------------1.44B-1.03B372.32M823.84M1.01B1.07B660.09M
Dividends Paid26.60M---33.48M148.05M102.34M120.43M139.82M66.23M134.02M-180.01M288.14M130.99M72.30M84.50M92.10M------
FCF to OCF-----------------132.94%181.12%59.35%78.74%84.06%75.25%73.14%
Dividend Paid to FCF------------------6.41%------

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------
EPS Actual0.060.25-0.08-0.020.240.190.120.120.280.100.15-0.080.080.110.01-0.180.070.06-0.01-0.02-0.15-0.28-0.34-0.54-0.25-0.05-0.240.02-0.490.080.03-0.14-0.300.08-0.20-0.55-0.010.13-0.090.15-0.110.20-0.060.17-0.190.210.220.12-0.030.140.160.24-0.250.220.240.330.290.250.47
Surprise-----------------------------------------------------------
Timing-----------------------------------------------------------

Key Statistics & Ratios

Market Cap10.22B
Enterprise Value13.32B
Trailing P/E37.88
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.47
Price / Book24.45
EPS0.66
Book Value2.58
Revenue (TTM)21.63B
Gross Profit (TTM)6.04B
EBITDA1.49B
Profit Margin1.52%
Operating Margin7.38%
Return on Equity36.52%
Return on Assets7.74%
Shares Outstanding358.84M
Shares Float14.06M
Beta0.13
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20141×
0.32May 7, 2014
20132×
0.41Nov 6, 20130.29May 6, 2013
20121×
0.44Oct 26, 2012
20102×
0.16Oct 6, 20100.16May 5, 2010
20092×
0.08Oct 16, 20090.08May 5, 2009
20083×
0.10Dec 3, 20080.08Oct 1, 20080.16Apr 29, 2008
20072×
0.10Nov 7, 20070.18Apr 26, 2007
20062×
0.14Sep 20, 20060.10Apr 24, 2006
20053×
0.19Oct 31, 20050.17Apr 27, 20050.10Apr 25, 2005
20041×
0.08Apr 28, 2004
20001×
0.21May 4, 2000
19991×
0.19May 7, 1999
19981×
0.19Apr 28, 1998
19971×
0.23Apr 28, 1997